Literature DB >> 27020815

Effects of intraosseous epinephrine in a cardiac arrest swine model.

Marc R Wong1, Matt J Reggio1, Freddy R Morocho1, Monica M Holloway1, Jose C Garcia-Blanco2, Constance Jenkins1, Arthur D Johnson3.   

Abstract

BACKGROUND: Interruptions in cardiopulmonary resuscitation (CPR) to obtain vascular access reduces blood flow to vital organs. Tibial intraosseous (TIO) access may be a faster alternative to intravenous (IV) access for delivery of vasoactive medications. The purpose of this study was to examine the differences in pharmacokinetics and pharmacodynamics of TIO- and IV-delivered epinephrine.
MATERIALS AND METHODS: A prospective, between subjects, experimental design comparing Cmax, Tmax, return of spontaneous circulation (ROSC), and time to ROSC. Adult male swine were divided into three equal groups (n = 7) all received CPR and defibrillation: the second group received IV epinephrine and the third group received tibial intraosseous epinephrine. Swine were placed in cardiac arrest for 2 min before CPR was initiated. After 2 min of CPR, epinephrine was delivered by IV or TIO, and serial blood samples were collected over 4 min.
RESULTS: There were no significant differences between IV versus TIO epinephrine in achieving ROSC, time to ROSC, and Cmax. A one-way analysis of variance demonstrated a significant difference between the IV and TIO groups in Tmax (P = 0.025). A Fisher exact test demonstrated a significant difference between IV epinephrine versus CPR/Defib only (P = 0.035) and TIO epinephrine versus CPR/Defib only (P = 0.010) in achieving ROSC. A multivariate analysis of variance showed significant differences in IV versus intraosseous epinephrine concentration at specific time intervals: 60 (P = 0.023), 90 (P = 0.001), and 120 (P < 0.000) sec.
CONCLUSIONS: In the context of ROSC, epinephrine delivered via TIO route is a clinically relevant alternative to IV administration. When IV access cannot be immediately obtained in cardiac arrest patients, TIO access should be considered. Published by Elsevier Inc.

Entities:  

Keywords:  Cardiopulmonary resuscitation; Epinephrine; Intraosseous; Intravenous; Pharmacokinetics; Return of spontaneous circulation

Mesh:

Substances:

Year:  2015        PMID: 27020815     DOI: 10.1016/j.jss.2015.11.015

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  [A new method for establishing a ventricular fibrillation model by TCEI in Tibetan miniature pig].

Authors:  Guodong Liang; Rugang Zheng; Hongjian Jian; Minhai Zhang; Huiqiong Yuan; Jiemin Hong; Gang Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-11-30

2.  Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest.

Authors:  Mohamud R Daya; Brian G Leroux; Paul Dorian; Thomas D Rea; Craig D Newgard; Laurie J Morrison; Joshua R Lupton; James J Menegazzi; Joseph P Ornato; George Sopko; Jim Christenson; Ahamed Idris; Purav Mody; Gary M Vilke; Caroline Herdeman; David Barbic; Peter J Kudenchuk
Journal:  Circulation       Date:  2020-01-16       Impact factor: 29.690

3.  Validation of intraosseous delivery of valproic acid in a swine model of polytrauma.

Authors:  Ben E Biesterveld; Rachel O'Connell; Michael T Kemp; Glenn K Wakam; Aaron M Williams; Manjunath P Pai; Hasan B Alam
Journal:  Trauma Surg Acute Care Open       Date:  2021-03-17

4.  Administration of epinephrine by advanced emergency medical technicians for out-of-hospital cardiac arrest in a rural emergency medical services system.

Authors:  Jared J Bomba; Jamie Benson; David Hosmer; Daniel Wolfson
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-10-13

5.  Effects of humeral intraosseous epinephrine in a pediatric hypovolemic cardiac arrest porcine model.

Authors:  Michael James Neill; James M Burgert; Dawn Blouin; Benjamin Tigges; Kari Rodden; Rachel Roberts; Phillip Anderson; Travis Hallquist; John Navarro; Joseph O'Sullivan; Don Johnson
Journal:  Trauma Surg Acute Care Open       Date:  2020-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.